Le Lézard
Classified in: Business
Subjects: NPT, SVY, ECO

Survey: In 2024, CEOs Are Most Worried About a Recession & Inflation, But Say They're Not Ready


NEW YORK, Jan. 10, 2024 /PRNewswire/ -- As the new year begins, what will keep the world's executives up at night? CEOs in both the United States and globally are bracing for a recession and elevated inflation.

Despite these issues topping their worry list, just 37% of US CEOs say they are prepared for a recession, and 34% are prepared for high inflation, according to a survey from The Conference Board.

Amid elevated inflation and a potential downturn, CEOs' plans to grow profits in 2024 include introducing new products/services, investing in technology, increasing sales via marketing, and entering new markets.

C-Suite Outlook 2024 also reveals that CEOs have thrown up their hands when it comes to getting workers back into the office full time. Just 4% of US CEOs say they will prioritize a full-time return to the office. Consistent with past surveys, attracting and retaining talent remains the number-one internal focus for CEOs globally. 

While the survey reveals that CEOs and boards are fairly well aligned on ESG priorities, with education and economic opportunity topping the list, boards are less confident than executives that their companies are addressing ESG issues effectively, including rising ESG backlash.

Additionally, wars in the Middle East and Ukraine are top of mind, but for America's CEOs the biggest geopolitical threat is at home: the ballooning national debt, which they put as their top geopolitical risk in 2024.

The survey reflects the views of more than 1,200 executives, including 630 CEOs. Participants weighed in on the top business threats and opportunities in 2024. Respondents were primarily from four regions: the United States, Latin America, Japan, and Europe.

Highlights from C-Suite Outlook 2024 include:

RECESSION & INFLATION
The biggest fear for 2024: CEOs expect a recession.

Despite cooling in 2023, inflation remains high on the worry list.

Most CEOs say their companies aren't prepared to navigate a recession or inflation crisis.

BORROWING COSTS
CEO anxiety surges over higher borrowing costs.

PLANS FOR GROWTH
For short-term profit growth, CEOs are prioritizing new products, new markets, tech investments & marketing.

For long-term revenue growth, they'll invest in innovation, digital transformation, new business, marketing & talent.

GEOPOLITICS
For America's CEOs, the biggest geopolitical risk is at home: the national debt.

CEOs worldwide are preoccupied by wars and escalating global tensions.

RETURN TO OFFICE & HUMAN CAPITAL
RIP: The battle over returning to the office.

Labor shortages and talent issues factor into the decision to end the return-to-office battle.

ARTIFICIAL INTELLIGENCE
CEOs strongly embrace AI?and fear falling behind more than the technology's dangers.

Are CEOs underestimating AI's risks?

ESG
CEOs see the benefits of clean energy, but are not making renewable energy investment a priority.

Boards and CEOs are aligned on ESG priorities, but boards are less confident on how the company is doing.

About The Conference Board
The Conference Board is the member-driven think tank that delivers trusted insights for what's ahead. Founded in 1916, we are a non-partisan, not-for-profit entity holding 501 (c) (3) tax-exempt status in the United States. www.conference-board.org

SOURCE The Conference Board


These press releases may also interest you

at 00:23
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 17, 2024. OKX to...

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Velan Inc. ("Velan" or the "Company"), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless...

16 mai 2024
TSX VENTURE COMPANIES BULLETIN V2024-1467 DECISIVE DIVIDEND CORPORATION ("DE")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  May 16, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend per common share:...



News published on and distributed by: